PT Medikaloka Hermina Tbk (ISX:HEAL) Beta: 0.4706 (As of Jul. 02, 2026)


ISX:HEAL PT Medikaloka Hermina Tbk ISX:HEAL
72 GF Score
Price Rp840.00
GF Value Rp1,577.62
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is PT Medikaloka Hermina Tbk Beta?

PT Medikaloka Hermina Tbk ISX:HEAL -0.59% 72 Beta is 0.4706 as of Jul. 02, 2026. GuruFocus rates ISX:HEAL with a GF Score™ of 72/100 and a GF Value™ of Rp1,577.62 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-02), PT Medikaloka Hermina Tbk's Beta is 0.4706.


PT Medikaloka Hermina Tbk  (ISX:HEAL) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


PT Medikaloka Hermina Tbk Beta Related Terms


PT Medikaloka Hermina Tbk Beta Historical Data

* Premium members only.

The historical data trend for PT Medikaloka Hermina Tbk's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Medikaloka Hermina Tbk Beta Chart

PT Medikaloka Hermina Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.88 0.92 -0.16 0.23 0.49

PT Medikaloka Hermina Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.65 0.36 0.55 0.49 0.30

ISX:HEAL vs HCA, THC, DVA: Beta Comparison

For the Medical Care Facilities subindustry, PT Medikaloka Hermina Tbk's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Medikaloka Hermina Tbk Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Medikaloka Hermina Tbk's Beta distribution charts can be found below:

* The bar in red indicates where PT Medikaloka Hermina Tbk's Beta falls into.


ISX:HEAL
72GF Score
PT Medikaloka Hermina Tbk ISX:HEAL
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Medikaloka Hermina Tbk Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.4706 mean?
PT Medikaloka Hermina Tbk (ISX:HEAL) has a Beta of 0.4706 as of Jul. 02, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for PT Medikaloka Hermina Tbk and its competitors.
Is PT Medikaloka Hermina Tbk's Beta too high?
PT Medikaloka Hermina Tbk's current Beta is 0.4706. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's Beta compare to HCA and THC?
PT Medikaloka Hermina Tbk's Beta of 0.4706 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for PT Medikaloka Hermina Tbk and its competitors. PT Medikaloka Hermina Tbk's current Beta is 0.4706. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,577.62, compared to a current price of Rp840.00 — trading 46.8% below its estimated fair value. The current Beta is 0.4706. PT Medikaloka Hermina Tbk's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current Beta is 0.4706 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?

Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued. The current stock price of Rp840.00 is trading 46.8% below its estimated GF Value™ of Rp1,577.62. GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.

Key valuation signals for ISX:HEAL:

  • Beta: 0.4706
  • GF Value™: Rp1,577.62 vs. price of Rp840.00 (46.8% below fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Medikaloka Hermina Tbk Business Description

Address Jalan Selangit B-10 Kavling No. 4, Hermina Tower, Kemayoran, Jakarta, IDN, 10610
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
72GF Score

Get the complete analysis for ISX:HEAL

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp840.00
Price
Rp1,577.62
GF Value